2m 2m 2m 2m 2m 2m 2m
Geron (GERN)
NASDAQ
$1.35-$0.005 (-0.37%)
Price as of Jun 23, 2026 7:46 PM EDT- $859.6MMarket Cap
- -5.63%1-Year Change
- BiotechnologyIndustry
Geron (GERN)
$1.35-$0.005 (-0.37%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 183.6M -37.66% | 294.6M +124,189.45% | 237,000 -60.23% | 596,000 -57.21% | |
Cost of Revenue | 4.7M +277.79% | 1.3M N/A | N/A N/A | N/A N/A | |
Gross Profit | 178.9M -39.01% | 293.3M +123,659.49% | 237,000 -60.23% | 596,000 -57.21% | |
Sales and Marketing Expense | 159.3M +9.28% | 145.7M N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -71.4M -31.14% | -103.7M -17.04% | -125.0M +30.91% | -95.5M +11.42% | |
Depreciation and Amortization Expense | 474,000 -13.19% | 546,000 +23.53% | 442,000 +53.47% | 288,000 +33.95% | |
Total Operating Expenses | 252.5M +0.69% | 250.7M +29.12% | 194.2M +39.55% | 139.1M +20.59% | |
Operating Profit | -68.6M -60.52% | -173.7M -10.42% | -193.9M +39.98% | -138.6M +21.54% | |
Interest Income | 18.1M -7.60% | 19.6M +8.02% | 18.2M +617.75% | 2.5M +379.89% | |
Interest Expense | -14.9M -19.48% | -18.5M +122.62% | -8.3M +20.78% | -6.9M +84.01% | |
Interest Income and Expense and Net | 3.2M +191.66% | 1.1M -88.79% | 9.8M +326.05% | -4.4M +35.48% | |
Total Nonoperating Income and Expense | -375,000 +58.90% | -236,000 +926.09% | -23,000 -102.30% | 1.0M -8.91% | |
Income before Taxes | -68.6M -60.52% | -173.7M -10.42% | -193.9M +39.98% | -138.6M +21.54% | |
Income Taxes | 75,000 -83.30% | 449,000 N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -83.5M -52.17% | -174.6M -5.19% | -184.1M +29.76% | -141.9M +22.21% | |
Net Income from Continuing Operations Applicable to Common | -83.5M -52.17% | -174.6M -5.19% | -184.1M +29.76% | -141.9M +22.21% | |
Basic EPS and Net Income | -0.13 -51.85% | -0.27 -15.62% | -0.32 -13.51% | -0.37 +5.71% | |
Diluted EPS and Net Income | -0.13 -51.85% | -0.27 -15.62% | -0.32 -13.51% | -0.37 +5.71% | |
Basic Weighted Average Shares | 666.7M +3.19% | 646.0M +13.21% | 570.6M +49.86% | 380.8M +16.22% | |
Diluted Weighted Average Shares | 666.7M +3.19% | 646.0M +13.21% | 570.6M +49.86% | 380.8M +16.22% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 77.6M -1.84% | 79.0M +12.84% | 70.0M +23.18% | 56.8M +63.02% | |
Short-Term Investments | N/A N/A | 327.6M +24.22% | 263.7M +127.50% | 115.9M -22.14% | |
Cash and Cash Equivalents and Short-Term Investments | 77.6M -80.92% | 406.6M +21.84% | 333.7M +93.17% | 172.7M -5.97% | |
Total Current Assets | 520.3M +5.96% | 491.0M +43.84% | 341.3M +89.38% | 180.2M -3.72% | |
Accumulated Depreciation | 2.2M +29.88% | 1.7M +37.86% | 1.2M +37.39% | 896,000 +37.85% | |
Property and Plant and Equipment and Net | 884,000 -32.52% | 1.3M +11.30% | 1.2M +48.42% | 793,000 +22.00% | |
Total Long-Term Assets | 884,000 -32.52% | 1.3M +11.30% | 1.2M +48.42% | 793,000 +22.00% | |
Total Assets | 570.5M -3.91% | 593.8M +50.68% | 394.1M +106.78% | 190.6M -15.69% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | 46.9M 0.00% | 46.9M +123.89% | 20.9M N/A | |
Total Current Liabilities | 111.5M +26.32% | 88.3M -18.30% | 108.1M +40.91% | 76.7M +68.48% | |
Total Long-Term Debt | 119.5M +0.90% | 118.5M +238.01% | 35.1M +16.02% | 30.2M -39.37% | |
Total Long-Term Liabilities | 121.0M +0.21% | 120.7M +217.27% | 38.1M +12.32% | 33.9M -37.37% | |
Total Liabilities | 344.7M +9.96% | 313.5M +114.51% | 146.1M +32.15% | 110.6M +11.00% | |
Retained Earnings | -1.9B +4.71% | -1.8B +10.93% | -1.6B +13.03% | -1.4B +11.16% | |
Total Stockholders Equity | 225.9M -19.42% | 280.3M +13.06% | 247.9M +209.94% | 80.0M -36.72% | |
Total Shares Outstanding | 639.9M +5.52% | 606.4M +11.28% | 544.9M +39.63% | 390.3M +20.55% | |
Cash Flow | |||||
Cash from Operating Activities | -111.0M -49.21% | -218.6M +30.33% | -167.7M +31.69% | -127.4M +33.30% | |
Capital Expenditures | N/A N/A | 680,000 -18.07% | 830,000 +92.58% | 431,000 +108.21% | |
Cash from Investing Activities | 107.2M +201.17% | -106.0M -41.21% | -180.3M -390.53% | 62.1M -13.73% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 2.3M -99.32% | 334.4M -7.64% | 362.0M +314.86% | 87.3M +79.72% | |
Financials Ratio | |||||
Gross Margin | 97.42% -2.17% | 99.57% N/A | N/A N/A | N/A N/A | |
Operating Margin | -37.35% -36.67% | -58.98% -99.93% | -81,832.91% +252.02% | -23,246.64% +184.06% | |
Return on Assets | -14.34% -59.42% | -35.34% -43.89% | -62.99% -7.54% | -68.12% +45.72% | |
Return on Equity | -32.99% -50.08% | -66.09% -41.14% | -112.29% -18.33% | -137.49% +99.74% | |
Revenue Growth | -37.66% -100.03% | 124,189.45% +206,275.24% | -60.23% +5.28% | -57.21% -112.70% | |
Current Ratio | 4.66 -16.12% | 5.56 +76.05% | 3.16 +34.40% | 2.35 -42.85% | |
Cash Ratio | 0.70 -22.30% | 0.89 +38.12% | 0.65 -12.59% | 0.74 -3.24% | |
Debt-to-Equity Ratio | N/A N/A | 0.59 +78.49% | 0.33 -48.32% | 0.64 N/A | |
Debt-to-Assets Ratio | N/A N/A | 0.28 +33.96% | 0.21 -22.54% | 0.27 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow